Clinical Trial Update: Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating axillary sentinel or targeted lymph node biopsy alone after neoadjuvant chemotherapy in node-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer Female | Phase 2 | Status: UNKNOWN